Paxil Product Liability Suit Gets Second Look From Sen. Grassley
This article was originally published in The Pink Sheet Daily
Grassley follows up on report that claims GSK hid Paxil's suicide risk.
You may also be interested in...
MHRA determines law was insufficient to warrant criminal prosecution.
Neither has announced a firm timeline, and the difference between Pfizer's 'October' and Moderna's 'November' could be mere hours or a few weeks, but Pfizer, by dint of luck or experience, is now in a position to offer the more optimistic projection on when it will seek an EUA. Both firms release their Phase III trial protocols, which seem in line with US FDA guidance.